InvestorsHub Logo

JLS

Followers 62
Posts 7863
Boards Moderated 0
Alias Born 12/14/2004

JLS

Re: Phaeton post# 13510

Tuesday, 07/28/2015 2:58:44 AM

Tuesday, July 28, 2015 2:58:44 AM

Post# of 32022
Why is big Pharma afraid of MannKind?

When you speak of big Pharma, you automatically include all large pharmaceuticals; not just one, such as Sanofi.

Is that what you intended, or do you want to limit it to just Sanofi?

Otherwise, I tend to agree (and already mentioned) that one could logically question Sanofi's conviction to sell lots of Afrezza.

Are they not robbing Peter to pay Paul?

Some of Sanofi's drugs are coming off patent so maybe they have no choice.

Here's a possibility which would explain Sanofi's interest in Afrezza: Sanofi gives preferential price treatment to the distribution channel for packaged deals containing both Sanofi's long-lasting products and Afrezza; yet they do not offer the same discount on Afrezza alone, thus preventing packaged deals by their competitors at the same, or lower, price level. A problem with that is it could leave them vulnerable to both federal and state antitrust laws.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNKD News